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Abstract
Objective—As potential occupational exposure to nanomaterials becomes more prevalent, it is 
important that the principles of medical surveillance be considered for workers in the 
nanotechnology industry.
Methods—The principles of medical surveillance are reviewed to further the discussion of 
occupational health surveillance for workers exposed to nanomaterials.
Results—Because of the rapid evolution of nanotechnology, information may not be available to 
make a well-informed determination of all factors needed to evaluate risk of health effects from 
occupational exposure to nanomaterials.
Conclusion—Every workplace dealing with engineered nanomaterials should conduct hazard 
and exposure assessments as part of an overall surveillance needs assessment for nanotechnology 
workers. In workplaces where risk is felt to be present, or at least cannot be ruled out, initiation of 
medical surveillance is prudent to protect workers’ health.
The principles of medical surveillance are an essential component of occupational health 
practice.1-3 As the production of (and potential occupational exposure to) nanomaterials 
becomes more prevalent, it is important that these principles be considered for workers in 
the nanotechnology industry.
DEFINITIONS AND BACKGROUND
Occupational health surveillance is the ongoing systematic collection, analysis, and 
dissemination of exposure and health data on groups of workers for the purpose of 
preventing illness and injury. Occupational health surveillance can help to define the 
magnitude and scope of occupational health issues among groups of workers, with the 
ultimate goal of prevention; occupational surveillance data are used to guide efforts to 
improve worker safety and health and monitor trends over time. The general term 
occupational health surveillance includes hazard and medical surveillance. Although the 
focus here concerns medical surveillance, integration of hazard and medical surveillance is 
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key to an effective occupational health surveillance program, and surveillance for disease or 
other health endpoints should not proceed without having a hazard surveillance program in 
place.4
The terms medical surveillance andmedical screening have sometimes been used 
interchangeably (and sometimes inconsistently) in the past, and it is important to understand 
distinctions between these activities.5 Medical surveillance describes activities that target 
health events or a change in a biologic function of an exposed person or persons. A 
surveillance program involves recurrent longitudinal examinations and data analysis over 
time. Medical screening is a complementary activity, sometimes considered one form of 
medical surveillance, that is designed to detect early signs of work-related illness by 
administering tests to apparently healthy persons in a cross-sectional approach.5 The term 
medical monitoring has been assigned different meanings in the past, but it is most 
appropriately seen as analogous to screening. Screening activities generally have a more 
clinical focus when compared to surveillance (the screened person may be directly treated in 
response to the screening test), but medical screening data, collected in a standardized 
manner, aggregated, and evaluated over time, can also be evaluated as a part of a 
surveillance program.
Both medical surveillance and screening are second lines of defense behind the 
implementation of engineering, administrative, and work practice controls (including 
personal protective equipment). Surveillance and screening activities should be seen as 
mechanisms that occupational health care professionals can use to determine whether the 
usual prevention activities in the hierarchy of occupational health controls are effective.6 
Although both are the examples of secondary prevention, if the results of surveillance and 
screening efforts are extended to make interventions in the work-place, both may also 
represent primary prevention activities.
ELEMENTS OF A MEDICAL SURVEILLANCE PROGRAM
The elements of a medical surveillance program generally include the following:
1. Identification of the group(s) of workers for which surveillance or screening 
activities will be appropriate.
2. An initial medical examination and collection of medical and occupational 
histories.
3. Periodic medical examinations at regularly scheduled intervals, including specific 
medical screening tests when warranted.
4. More frequent and detailed medical examinations, as indicated on the basis of 
findings from these examinations.
5. Postincident examinations and medical screening after uncontrolled or nonroutine 
increases in exposures such as spills.
6. Ongoing data analyses to evaluate collected information for surveillance and/or 
screening purposes.
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7. Worker training to recognize symptoms of exposure to a given hazard.
8. A written report of medical findings.
9. Employer actions in response to the identification of potential hazards and risks to 
health.
These elements are present in many surveillance programs currently in use, including those 
based on medical screening and surveillance recommendations from the National Institute 
for Occupational Safety and Health (NIOSH). General information concerning surveillance 
may be found at the NIOSH Web site: www.cdc.gov/niosh/topics/surveillance/. Examples of 
specific information from NIOSH related to surveillance can be found in resources devoted 
to specific hazards, such as coal mining (www.cdc.gov/niosh/topics/surveillance/ords/
CoalWorkersHealthSurvProgram.html). The Occupational Safety and Health Administration 
also places great emphasis on surveillance and screening. Mandatory and nonmandatory 
medical surveillance programs used by the Occupational Safety and Health Administration 
are compiled at the following Web site: http://www.osha.gov/SLTC/medicalsurveillance/.
OTHER CONSIDERATIONS FOR MEDICAL SURVEILLANCE PROGRAMS
Clear Definitions of Purpose and Availability of Tests/Tools
A medical surveillance program should have a clearly defined purpose/objective and a 
defined target population, and testing modalities must be available to accomplish the defined 
objective. Testing modalities may include such tools as questionnaires, physical 
examinations, and medical testing. These types of evaluations are used within the target 
population to gain data concerning specific organ system(s) and more general information 
concerning potential health effects or exposure. Consideration given to potential routes of 
exposure is a logical means of helping to target medical evaluations. For example, if the 
route of potential exposure is thought to be inhalation, the pulmonary system may be 
targeted for medical evaluation. When considering specific testing modalities, existing 
toxicity information about a given nanomaterial on a larger scale can provide a baseline for 
anticipating the possible adverse health effects that may occur from exposure to that same 
material on a nanoscale.
Test Characteristics
Data collected in a surveillance program should be interpreted with some knowledge of the 
characteristics of the tools being used. Typically, ideal medical screening tests have high 
sensitivity (the test is positive in a high percentage of persons with the disease). 
Nevertheless, tests with high sensitivity often have low specificity (some workers with 
positive test results are actually free of disease [false positives]). In interpreting nonspecific 
tests, a careful examination with attention to occupational as well as known nonoccupational 
factors is necessary. The positive predictive value of a test is also of particular importance 
and will be dependent on the prevalence of the condition being evaluated in the target 
population.
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Those conducting medical surveillance and screening should understand the concepts of 
sentinel events4,7 and should be alert for unusual patterns of findings. In some instances, 
results of data analyses will alert practitioners to elevated rates of common diseases or 
common symptoms that warrant follow-up investigation. In other instances, data analyses 
will signal when a disease or illness occurs in excess or in a “cluster” in time and space. 
Expertise in epidemiologic principles is essential when analyzing and interpreting medical 
surveillance data and disease rates.3,8,9
Availability of Intervention
The availability of effective interventions is an important consideration in establishing a 
medical surveillance or screening program. The importance and effectiveness of a medical 
surveillance or screening program may be assessed by determining whether it was 
successful in leading to interventions that could decrease disease or illness.
Communication
An effective medical surveillance or screening program will require communication with a 
number of individuals or groups. On the basis of the identified purpose of the program, a 
clear plan should be established for interpreting the results and presenting the findings to 
workers and management of the affected workplace(s) in a manner that avoids creating false 
anxiety or false assurance. An explanation of the level of uncertainty associated with 
measurements should be routinely included in presentations to workers and management. 
Workers should be given a summary of the information in accordance with appropriate 
privacy and confidentiality protections.
Program Evaluation
An important part of any medical surveillance or screening program is assessing the overall 
program efficacy by evaluating the program in a number of ways. Quality assurance and 
control should be considered for all workplace sampling and medical testing. For medical 
tests, review or direct assessment of the laboratory’s quality assurance procedures should be 
considered. Another component of program evaluation is assessing the appropriateness of 
the target populations. For example, for those workers at risk of exposure to nanomaterials, 
what percentage actually participated in the medical surveillance program? Conversely, how 
much excess testing was done on workers without specific risk factors warranting the 
testing?
Management, Coordination, and Integration With Other Programs
Hazard or medical surveillance or screening and its individual components will not provide 
for effective occupational health surveillance without coordination of all aspects by a 
program manager. The occupational health surveillance program manager has the duty of 
integrating the surveillance components and providing input to maximize the effectiveness 
of all aspects of the program.
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CHALLENGES TO MEDICAL SURVEILLANCE/SCREENING OF 
NANOTECHNOLOGY WORKERS
A number of the elements of a standard medical surveillance program represent unique 
challenges when applied to surveillance for nanotechnology workers. Identification of 
workers potentially exposed to a hazardous substance, an important first step in the initiation 
of a surveillance program, may be challenging in the “field of nanotechnology.” A standard 
approach for the initiation of surveillance with known hazards (such as substances with a 
documented evidence base related to biomedical effects and an occupational exposure limit 
[OEL]) is to utilize the concept of an “action level,” which is some fraction of the OEL. 
Common practice has included triggering of various preventive actions such as a medical 
surveillance program based on worker exposure at or above the action level. Currently, in 
many situations, data concerning exposure are not available for properly assessing the need 
for medical surveillance or screening related to occupational exposure to nanomaterials. In 
the absence of OELs and attendant action levels for nanomaterials, medical surveillance for 
groups of potentially exposed workers should be considered on the basis of qualitative job 
hazard exposure analyses.8 In workplaces where risk (based on an assessment of the best-
available information concerning hazard and exposure) is felt to be present, or at least 
cannot be ruled out, initiation of medical surveillance is prudent to protect workers’ health. 
Such medical surveillance may consist, at a minimum, of collecting medical history 
information on a targeted population. A determination of whether medical surveillance is 
instituted, the components of the medical surveillance, and how frequently data are collected 
should be made on a workplace by workplace basis, influenced by the possible nature of the 
health effects associated with the nanomaterial, as derived from available information. When 
information concerning the degree of hazard associated with a nanomaterial is not known, as 
with many nanomaterials, various other approaches may need to be utilized-–for example, 
by determining whether toxicity information exists for a similar type of nanomaterial or 
larger-scale particles of the same composition that can be used as a surrogate for triggering 
action.10 Periodic reassessment of hazard and exposure will be a critical part of this needs 
assessment for a medical surveillance program.
The lack of specific screening tests for exposure or health endpoints related to nanomaterial 
exposure is a second important challenge. The utility of nonspecific medical screening is 
limited, because the health endpoints that may be linked to nanomaterials are not well 
known or confirmed at this time. Nonetheless, general medical screening may serve as an 
early warning system for possible, yet to be determined, health effects linked to exposure. 
This determination will require that the data be continually analyzed on a group basis and, if 
possible, linked to exposure and compared to appropriate comparison population rates. The 
limitation of this approach is that it may identify health effects unrelated to nanomaterial 
exposure (and in some cases, false positives, which may require follow-up and further 
diagnostic evaluation). It may also give screened employees a false sense that such 
procedures would be sensitive to any health risk associated with exposure to nanomaterials.
Our ability to address these and other challenges will be improved as our knowledge related 
to occupational exposure to nano-materials grows. Some of these challenges can be partially 
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addressed in current worksites where workers are monitored through existing programs 
whether they work in areas with both regulated hazards (or hazards which may not be 
regulated but for which well-accepted medical monitoring procedures exist) and 
nanomaterials. For example, three such types of medical surveillance that may be occurring 
in a workplace include assessment of the worker’s ability to wear or use required respiratory 
or other personal protective equipment, medical examinations pertaining to job placement, 
and medical examinations as part of emergency medical care after a work-related exposure 
or incident. Employers should continue using these established applications of medical 
surveillance as appropriate and keep in mind that analyses of these data in the future with 
respect to current nanomaterial exposure may provide useful information concerning health 
effects potentially related to exposure to those nanomaterials.
CONCLUSIONS
Application of the principles of medical surveillance is essential in creating appropriate 
occupational health surveillance programs to fit the needs of workers and organizations 
involved with nanotechnology. Every workplace dealing with nanomaterials should conduct 
hazard and exposure assessments as part of an overall surveillance needs assessment for 
nanotechnology workers. In many situations currently, because of the rapid evolution of 
nanotechnology, information may not be available to make a well-informed determination of 
all the factors needed to evaluate risk of health effects from occupational exposure to 
nanomaterials. In workplaces where risk is felt to be present, or at least cannot be ruled out, 
initiation of medical surveillance is prudent to protect workers’ health. Periodic 
modifications to any initial medical surveillance programs for nanotechnology workers are 
likely to be necessary, as the knowledge base relative to potential hazards of occupational 
exposure to nanomaterials grows.
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